← Back to Search

Addressing Barriers to Care for Substance Use Disorder Trial (ABC-SUD Trial)

N/A
Waitlist Available
Led By Joseph E Glass, PhD, MSW
Research Sponsored by Kaiser Permanente
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
* Conducts assessment and treatment planning visits in the mental health access center
* Has been employed for at least 1 month
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 48 days
Awards & highlights
No Placebo-Only Group

Summary

The Addressing Barriers to Care for Substance Use Disorder Trial (ABC-SUD) is a cluster-randomized crossover trial, with clinicians (care coordinators) as the unit of randomization. This study will be conducted in a mental health access center within the Washington region of Kaiser Permanente. As part of usual care, patients contact the mental health access center and speak to a care coordinator to obtain an appointment with or contact information for potential venues to obtain treatment for substance use disorder. The experimental intervention, Care Navigation, will be evaluated for its potential to increase engagement in substance use disorder treatment among patients who contact the mental health access center. Care Navigation will be delivered by study care navigators, who are distinct from the health system's care coordinators.

Eligible Conditions
  • Alcohol Use Disorder
  • Addiction
  • Substance Use Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~48 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 days for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Engagement in treatment for substance use disorder
Secondary study objectives
Initiation of treatment for substance use disorder

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Care NavigationExperimental Treatment1 Intervention
Mental health care coordinators are able to offer and refer patients to a care navigator in addition to offering substance use resources and treatment options as usual.
Group II: Services as UsualActive Control1 Intervention
Mental health care coordinators will continue offering substance use resources and treatment options to patients as usual.

Find a Location

Who is running the clinical trial?

Stanford UniversityOTHER
2,486 Previous Clinical Trials
17,517,333 Total Patients Enrolled
Kaiser PermanenteLead Sponsor
555 Previous Clinical Trials
27,731,754 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,599 Previous Clinical Trials
3,328,955 Total Patients Enrolled
Joseph E Glass, PhD, MSWPrincipal InvestigatorKaiser Permanente
3 Previous Clinical Trials
14,592 Total Patients Enrolled
~240 spots leftby Aug 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top